Skip to main content
Erschienen in: AIDS and Behavior 10/2019

10.04.2019 | Original Paper

Factors Associated with PrEP Refusal Among Transgender Women in Northeastern Brazil

verfasst von: Fabiane Soares, Sarah MacCarthy, Laio Magno, Luís Augusto Vasconcelos da Silva, Leila Amorim, Amy Nunn, Catherine E. Oldenburg, Inês Dourado, The PopTrans Group

Erschienen in: AIDS and Behavior | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Brazil has recently integrated HIV Pre-exposure Prophylaxis (PrEP) into its public health system and offered to key populations such as transgender women (TGW). This study investigates factors associated with PrEP refusal among TGW living in one of the largest and poorest cities of Brazil. We recruited 127 TGW using Respondent Driven Sampling (RDS) in Salvador, Brazil. Latent class analysis (LCA) was used to define acceptability of PrEP. Two latent classes were identified: “high acceptability of PrEP” (91.3%) and “PrEP refusal” (8.7%). PrEP was less acceptable among white TGW and among those age 25 or older, with income above minimum wage (≥ US$252.87), and reporting unprotected receptive anal intercourse with (URAI) causal partners. The findings highlight how nuanced strategies that takes into consideration unique characteristics are needed to effectively address the acceptability of PrEP.
Literatur
2.
Zurück zum Zitat Baral SD, Poteat T, Strömdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22.PubMedCrossRef Baral SD, Poteat T, Strömdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22.PubMedCrossRef
3.
Zurück zum Zitat Grinsztejn B, Jalil EM, Monteiro L, et al. Unveiling of HIV dynamics among transgender women: a respondent-driven sampling study in Rio de Janeiro, Brazil. Lancet HIV. 2017;4(4):e169–76.PubMedPubMedCentralCrossRef Grinsztejn B, Jalil EM, Monteiro L, et al. Unveiling of HIV dynamics among transgender women: a respondent-driven sampling study in Rio de Janeiro, Brazil. Lancet HIV. 2017;4(4):e169–76.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.PubMedPubMedCentralCrossRef Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.PubMedPubMedCentralCrossRef Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Montgomery MC, Oldenburg CE, Nunn AS, et al. Adherence to pre-exposure prophylaxis for HIV prevention in a clinical setting. PLoS ONE. 2016;11(6):e0157742.PubMedPubMedCentralCrossRef Montgomery MC, Oldenburg CE, Nunn AS, et al. Adherence to pre-exposure prophylaxis for HIV prevention in a clinical setting. PLoS ONE. 2016;11(6):e0157742.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Parker S, Chan PA, Oldenburg CE, et al. Patient experiences of men who have sex with men using pre-exposure prophylaxis to prevent HIV infection. AIDS Patient Care STDS. 2015;29(12):639–42.PubMedPubMedCentralCrossRef Parker S, Chan PA, Oldenburg CE, et al. Patient experiences of men who have sex with men using pre-exposure prophylaxis to prevent HIV infection. AIDS Patient Care STDS. 2015;29(12):639–42.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Chan PA, Glynn TR, Oldenburg CE, et al. Implementation of preexposure prophylaxis for human immunodeficiency virus prevention among men who have sex with men at a new england sexually transmitted diseases clinic. Sex Transm Dis. 2016;43(11):717–23.PubMedPubMedCentralCrossRef Chan PA, Glynn TR, Oldenburg CE, et al. Implementation of preexposure prophylaxis for human immunodeficiency virus prevention among men who have sex with men at a new england sexually transmitted diseases clinic. Sex Transm Dis. 2016;43(11):717–23.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Sevelius JM, Deutsch MB, Grant R. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016;19(Suppl 6):21105.PubMedPubMedCentral Sevelius JM, Deutsch MB, Grant R. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016;19(Suppl 6):21105.PubMedPubMedCentral
11.
Zurück zum Zitat Deutsch MB, Glidden DV, Sevelius J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015;2(12):e512–9.PubMedPubMedCentralCrossRef Deutsch MB, Glidden DV, Sevelius J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015;2(12):e512–9.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Paim J, Travassos C, Almeida C, Bahia L, Macinko J. Health in Brazil 1. The Brazilian health system: history, advances, and challenges. Lancet. 2011;377(377):1778–97.PubMedCrossRef Paim J, Travassos C, Almeida C, Bahia L, Macinko J. Health in Brazil 1. The Brazilian health system: history, advances, and challenges. Lancet. 2011;377(377):1778–97.PubMedCrossRef
13.
Zurück zum Zitat Nunn AS, Massard E, Fonseca D, Bastos FI, Gruskin S, Nunn A. AIDS treatment in Brazil: impacts and challenges. Heal Aff (Millwood). 2009;28(4):1103–13.CrossRef Nunn AS, Massard E, Fonseca D, Bastos FI, Gruskin S, Nunn A. AIDS treatment in Brazil: impacts and challenges. Heal Aff (Millwood). 2009;28(4):1103–13.CrossRef
14.
Zurück zum Zitat Hoagland B, De Boni RB, Moreira RI, et al. Awareness and willingness to use pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women in Brazil. AIDS Behav. 2017;21(5):1278–87.PubMedCrossRef Hoagland B, De Boni RB, Moreira RI, et al. Awareness and willingness to use pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women in Brazil. AIDS Behav. 2017;21(5):1278–87.PubMedCrossRef
16.
Zurück zum Zitat Luz PM, Benzaken A, de Alencar TM, Pimenta C, Veloso VG, Grinsztejn B. PrEP adopted by the brazilian national health system: what is the size of the demand? Medicine (Baltimore). 2018;97(Suppl 1):S75–7.PubMedPubMedCentralCrossRef Luz PM, Benzaken A, de Alencar TM, Pimenta C, Veloso VG, Grinsztejn B. PrEP adopted by the brazilian national health system: what is the size of the demand? Medicine (Baltimore). 2018;97(Suppl 1):S75–7.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Mensch BS, van der Straten A, Katzen LL. Acceptability in microbicide and PrEP trials: current status and a reconceptualization. Curr Opin HIV AIDS. 2012;7(6):534–41.PubMedPubMedCentralCrossRef Mensch BS, van der Straten A, Katzen LL. Acceptability in microbicide and PrEP trials: current status and a reconceptualization. Curr Opin HIV AIDS. 2012;7(6):534–41.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Dolezal C, Frasca T, Giguere R, et al. Awareness of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) is low but interest is high among men engaging in condomless anal sex with men in Boston, Pittsburgh, and San Juan. AIDS Educ Prev. 2015;27(4):289–97.PubMedPubMedCentralCrossRef Dolezal C, Frasca T, Giguere R, et al. Awareness of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) is low but interest is high among men engaging in condomless anal sex with men in Boston, Pittsburgh, and San Juan. AIDS Educ Prev. 2015;27(4):289–97.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009;50(1):77–83.PubMedPubMedCentralCrossRef Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009;50(1):77–83.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Frankis JS, Young I, Lorimer K, Davis M, Flowers P. Towards preparedness for PrEP: PrEP awareness and acceptability among MSM at high risk of HIV transmission who use sociosexual media in four Celtic nations: Scotland, Wales, Northern Ireland and The Republic of Ireland: an online survey. Sex Transm Infect. 2016;92(4):6.CrossRef Frankis JS, Young I, Lorimer K, Davis M, Flowers P. Towards preparedness for PrEP: PrEP awareness and acceptability among MSM at high risk of HIV transmission who use sociosexual media in four Celtic nations: Scotland, Wales, Northern Ireland and The Republic of Ireland: an online survey. Sex Transm Infect. 2016;92(4):6.CrossRef
21.
Zurück zum Zitat Oldenburg CE, Le B, Toan T, et al. HIV pre-exposure prophylaxis indication and readiness among HIV-uninfected transgender women in Ho Chi Minh City, Vietnam. AIDS Behav. 2016;20(Suppl 3):365–70.PubMedPubMedCentralCrossRef Oldenburg CE, Le B, Toan T, et al. HIV pre-exposure prophylaxis indication and readiness among HIV-uninfected transgender women in Ho Chi Minh City, Vietnam. AIDS Behav. 2016;20(Suppl 3):365–70.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Barbosa Júnior A, Pascom ARP, Szwarcwald CL, Kendall C, McFarland W. Transfer of sampling methods for studies on most-at-risk populations (MARPs) in Brazil. Cad Saude Publica. 2011;27(suppl 1):s36–44.PubMedCrossRef Barbosa Júnior A, Pascom ARP, Szwarcwald CL, Kendall C, McFarland W. Transfer of sampling methods for studies on most-at-risk populations (MARPs) in Brazil. Cad Saude Publica. 2011;27(suppl 1):s36–44.PubMedCrossRef
24.
Zurück zum Zitat Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRef Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRef
25.
Zurück zum Zitat Johnston LG, Sabin K. Sampling hard-to-reach populations with respondent driven sampling. Methodol Innov Online. 2010;5(2):38–48. Johnston LG, Sabin K. Sampling hard-to-reach populations with respondent driven sampling. Methodol Innov Online. 2010;5(2):38–48.
26.
Zurück zum Zitat MacCarthy S, Reisner S, Hoffmann M, et al. Mind the gap: implementation challenges break the link between HIV/AIDS research and practice. Cad Saúde Pública. 2016;32(10):e00047715.PubMedPubMedCentralCrossRef MacCarthy S, Reisner S, Hoffmann M, et al. Mind the gap: implementation challenges break the link between HIV/AIDS research and practice. Cad Saúde Pública. 2016;32(10):e00047715.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Kerr LRFS, Mota RS, Kendall C, et al. HIV among MSM in a large middle-income country. Wolters Kluwer Health AIDS. 2013;27:427–35. Kerr LRFS, Mota RS, Kendall C, et al. HIV among MSM in a large middle-income country. Wolters Kluwer Health AIDS. 2013;27:427–35.
28.
Zurück zum Zitat Baptista CJ, Dourado I, Brignol S, de Matos Andrade T, Bastos FI. Factors associated with syphilis seroreactivity among polydrug users in Northeast Brazil: a cross-sectional study using Respondent Driven Sampling. Int J Drug Policy. 2017;1(39):37–42.CrossRef Baptista CJ, Dourado I, Brignol S, de Matos Andrade T, Bastos FI. Factors associated with syphilis seroreactivity among polydrug users in Northeast Brazil: a cross-sectional study using Respondent Driven Sampling. Int J Drug Policy. 2017;1(39):37–42.CrossRef
29.
Zurück zum Zitat Chan PA, Rose J, Maher J, et al. A latent class analysis of risk factors for acquiring HIV among men who have sex with men: implications for implementing pre-exposure prophylaxis programs. AIDS Patient Care STDS. 2015;29(11):597–605.PubMedPubMedCentralCrossRef Chan PA, Rose J, Maher J, et al. A latent class analysis of risk factors for acquiring HIV among men who have sex with men: implications for implementing pre-exposure prophylaxis programs. AIDS Patient Care STDS. 2015;29(11):597–605.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Nunn A, Brinkley-Rubinstein L, Rose J, et al. Latent class analysis of acceptability and willingness to pay for self-HIV testing in a United States urban neighbourhood with high rates of HIV infection. J Int AIDS Soc. 2017;20(1):21290.PubMedPubMedCentralCrossRef Nunn A, Brinkley-Rubinstein L, Rose J, et al. Latent class analysis of acceptability and willingness to pay for self-HIV testing in a United States urban neighbourhood with high rates of HIV infection. J Int AIDS Soc. 2017;20(1):21290.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Collins LM, Lanza ST. Latent class and latent transition analysis: with applications in the social behavioral, and health sciences. 1st ed. Los Angeles: Wiley; 2010. p. 285. Collins LM, Lanza ST. Latent class and latent transition analysis: with applications in the social behavioral, and health sciences. 1st ed. Los Angeles: Wiley; 2010. p. 285.
32.
Zurück zum Zitat Celeux G, Soromenho G. An entropy criterion for assessing the number of clusters in a mixture model. J Classif. 1996;13(2):195–212.CrossRef Celeux G, Soromenho G. An entropy criterion for assessing the number of clusters in a mixture model. J Classif. 1996;13(2):195–212.CrossRef
33.
Zurück zum Zitat Burnham KP, Anderson DR. Model selection and multimodel inference: a practical information-theoretic approach. New York: Springer; 2002. p. 488. Burnham KP, Anderson DR. Model selection and multimodel inference: a practical information-theoretic approach. New York: Springer; 2002. p. 488.
34.
Zurück zum Zitat Henson JM, Reise SP, Kim KH. Detecting mixtures from structural model differences using latent variable mixture modeling: a comparison of relative model fit statistics. Struct Equ Model. 2007;14(2):202–26.CrossRef Henson JM, Reise SP, Kim KH. Detecting mixtures from structural model differences using latent variable mixture modeling: a comparison of relative model fit statistics. Struct Equ Model. 2007;14(2):202–26.CrossRef
35.
Zurück zum Zitat Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol. 2004;34:193–239.CrossRef Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol. 2004;34:193–239.CrossRef
36.
Zurück zum Zitat Muthén LK, Muthén BO. Mplus statistical analysis With latent variables user’s guide. 6th ed. Los Angeles: Muthén & Muthén; 2010. p. 758. Muthén LK, Muthén BO. Mplus statistical analysis With latent variables user’s guide. 6th ed. Los Angeles: Muthén & Muthén; 2010. p. 758.
37.
Zurück zum Zitat Tukey JW. Exploratory data analysis. Menlo Park: Addison-Wesley Pub. Co; 1977. p. 688. Tukey JW. Exploratory data analysis. Menlo Park: Addison-Wesley Pub. Co; 1977. p. 688.
38.
Zurück zum Zitat Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. J Off Stat. 2008;24(1):79–97. Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. J Off Stat. 2008;24(1):79–97.
39.
Zurück zum Zitat Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley; 2000. p. 376.CrossRef Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley; 2000. p. 376.CrossRef
40.
Zurück zum Zitat Garnett M, Hirsch-Moverman Y, Franks J, Hayes-Larson E, El-Sadr WM, Mannheimer S. Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York city. AIDS Care. 2018;30(1):9–17.PubMedCrossRef Garnett M, Hirsch-Moverman Y, Franks J, Hayes-Larson E, El-Sadr WM, Mannheimer S. Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York city. AIDS Care. 2018;30(1):9–17.PubMedCrossRef
41.
Zurück zum Zitat Draper BL, Oo ZM, Thein ZW, et al. Willingness to use HIV pre-exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar. J Int AIDS Soc. 2017;20(1):21885.PubMedPubMedCentralCrossRef Draper BL, Oo ZM, Thein ZW, et al. Willingness to use HIV pre-exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar. J Int AIDS Soc. 2017;20(1):21885.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Goedel WC, Perry Halkitis BN, Richard Greene BE, Duncan DT. Correlates of awareness of and willingness to use pre-exposure prophylaxis (PrEP) in gay, bisexual, and other men who have sex with men who use geosocial-networking smartphone applications in New York City. AIDS Behav. 2016;20:1435–42.PubMedCrossRef Goedel WC, Perry Halkitis BN, Richard Greene BE, Duncan DT. Correlates of awareness of and willingness to use pre-exposure prophylaxis (PrEP) in gay, bisexual, and other men who have sex with men who use geosocial-networking smartphone applications in New York City. AIDS Behav. 2016;20:1435–42.PubMedCrossRef
43.
Zurück zum Zitat Lebouché B, Engler K, Machouf N, Lessard D, Thomas R. Predictors of interest in taking pre-exposure prophylaxis among men who have sex with men who used a rapid HIV-testing site in Montreal (Actuel sur Rue). HIV Med. 2016;17(2):152–8.PubMedCrossRef Lebouché B, Engler K, Machouf N, Lessard D, Thomas R. Predictors of interest in taking pre-exposure prophylaxis among men who have sex with men who used a rapid HIV-testing site in Montreal (Actuel sur Rue). HIV Med. 2016;17(2):152–8.PubMedCrossRef
44.
Zurück zum Zitat Galea JT, Kinsler JJ, Salazar X, et al. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. Int J STD AIDS. 2011;22(5):256–62.PubMedPubMedCentralCrossRef Galea JT, Kinsler JJ, Salazar X, et al. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. Int J STD AIDS. 2011;22(5):256–62.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Wei S, Zou Y, Xu Y, et al. Acceptability and influencing factors of pre-exposure prophylaxis among men who have sex with men in Guangxi. Zhonghua Liu Xing Bing Xue Za Zhi. 2011;32(8):786–8.PubMed Wei S, Zou Y, Xu Y, et al. Acceptability and influencing factors of pre-exposure prophylaxis among men who have sex with men in Guangxi. Zhonghua Liu Xing Bing Xue Za Zhi. 2011;32(8):786–8.PubMed
46.
Zurück zum Zitat Biello KB, Hosek S, Drucker MT, et al. Preferences for injectable PrEP among young U.S. cisgender men and transgender women and men who have sex with men. Arch Sex Behav. 2017;47(7):2101–7.PubMedCrossRef Biello KB, Hosek S, Drucker MT, et al. Preferences for injectable PrEP among young U.S. cisgender men and transgender women and men who have sex with men. Arch Sex Behav. 2017;47(7):2101–7.PubMedCrossRef
47.
Zurück zum Zitat Meyers K, Rodriguez K, Moeller RW, Gratch I, Markowitz M, Halkitis PN. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 Cohort substudy. PLoS ONE. 2014;9(12):e114700.PubMedPubMedCentralCrossRef Meyers K, Rodriguez K, Moeller RW, Gratch I, Markowitz M, Halkitis PN. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 Cohort substudy. PLoS ONE. 2014;9(12):e114700.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013;27(4):248–54.PubMedPubMedCentralCrossRef Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013;27(4):248–54.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Van Minh H, Giang LM, Cashin C, Hinh ND. Health system research in Vietnam: generating policy-relevant knowledge. Glob Public Health. 2015;10(1):S1–4.CrossRef Van Minh H, Giang LM, Cashin C, Hinh ND. Health system research in Vietnam: generating policy-relevant knowledge. Glob Public Health. 2015;10(1):S1–4.CrossRef
50.
Zurück zum Zitat Beyrer C, Crago A-L, Bekker L-G, Butler J, Shannon K, Kerrigan D, et al. An action agenda for HIV and sex work. Lancet. 2015;385(9964):287–301.PubMedCrossRef Beyrer C, Crago A-L, Bekker L-G, Butler J, Shannon K, Kerrigan D, et al. An action agenda for HIV and sex work. Lancet. 2015;385(9964):287–301.PubMedCrossRef
51.
Zurück zum Zitat Boyce S, Barrington C, Bolaños H, Galindo Arandi C, Paz-Bailey G. Facilitating access to sexual health services for men who have sex with men and male-to-female transgender persons in Guatemala City. Cult Health Sex. 2012;14(3):313–27.PubMedCrossRef Boyce S, Barrington C, Bolaños H, Galindo Arandi C, Paz-Bailey G. Facilitating access to sexual health services for men who have sex with men and male-to-female transgender persons in Guatemala City. Cult Health Sex. 2012;14(3):313–27.PubMedCrossRef
52.
Zurück zum Zitat Sanchez NF, Sanchez JP, Danoff A. Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City. Am J Public Health. 2009;99(4):713–9.PubMedPubMedCentralCrossRef Sanchez NF, Sanchez JP, Danoff A. Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City. Am J Public Health. 2009;99(4):713–9.PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Young I, Flowers P, Mcdaid LM. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland. BMJ Open. 2014;4(11):8.CrossRef Young I, Flowers P, Mcdaid LM. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland. BMJ Open. 2014;4(11):8.CrossRef
54.
Zurück zum Zitat Yi S, Tuot S, Mwai GW, et al. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21580.PubMedPubMedCentralCrossRef Yi S, Tuot S, Mwai GW, et al. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21580.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Doniec K, Dall’Alba R, King L. Austerity threatens universal health coverage in Brazil. Lancet. 2016;388(10047):867–8.PubMedCrossRef Doniec K, Dall’Alba R, King L. Austerity threatens universal health coverage in Brazil. Lancet. 2016;388(10047):867–8.PubMedCrossRef
56.
Zurück zum Zitat Doniec K, Dall’Alba R, King L. Brazil’s health catastrophe in the making. Lancet. 2018;392(10149):731–2.PubMedCrossRef Doniec K, Dall’Alba R, King L. Brazil’s health catastrophe in the making. Lancet. 2018;392(10149):731–2.PubMedCrossRef
57.
Zurück zum Zitat Malta M. Human rights and political crisis in Brazil: public health impacts and challenges. Glob Public Health. 2018;13(11):1577–84.PubMedCrossRef Malta M. Human rights and political crisis in Brazil: public health impacts and challenges. Glob Public Health. 2018;13(11):1577–84.PubMedCrossRef
Metadaten
Titel
Factors Associated with PrEP Refusal Among Transgender Women in Northeastern Brazil
verfasst von
Fabiane Soares
Sarah MacCarthy
Laio Magno
Luís Augusto Vasconcelos da Silva
Leila Amorim
Amy Nunn
Catherine E. Oldenburg
Inês Dourado
The PopTrans Group
Publikationsdatum
10.04.2019
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 10/2019
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02501-z

Weitere Artikel der Ausgabe 10/2019

AIDS and Behavior 10/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.